Isoquinoline and quinuclidine derivative that acts as a 5-HT3 RECEPTOR antagonist. It is used in the prevention of nausea and vomiting induced by cytotoxic chemotherapy, and for the prevention of post-operative nausea and vomiting.
Also Known As:
Aloxi; 2-(1-azabicyclo(2.2.2)oct-3-yl)-2,3,3a,4,5,6-hexahydro-1H-benz(de)isoquinolin-1-one; 2-QHBIQO; Palonosetron Hydrochloride; Palonosetron, (3R)-; Palonosetron, (R-(R*,R*))-isomer; Palonosetron, (R-(R*,S*))-isomer; Palonosetron, (S-(R*,S*))-isomer; RS 25233-197; RS 25233-198; RS 25259; RS 25259-197; RS 25259-198; RS-25233-197; RS-25233-198; RS-25259; RS-25259-197; RS-25259-198; RS 25233 197; RS 25233 198; RS 25233197; RS 25233198; RS 25259 197; RS 25259 198; RS 25259197; RS 25259198; RS25233197; RS25233198; RS25259; RS25259197; RS25259198; 1H-Benz(de)isoquinolin-1-one, 2-((3S)-1-azabicyclo(2.2.2)oct-3-yl)-2,3,3a,4,5,6-hexahydro-, (3aS)-